Palvella Therapeutics (PVLA) Change in Taxes (2014 - 2015)
Palvella Therapeutics (PVLA) posted quarterly Change in Taxes of $12474.0 for Q3 2015, down 74.58% year-over-year from $49064.0 in Q3 2014, and up 6991.71% quarter-over-quarter from -$181.0 in Q2 2015.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Change in Taxes (2014 - 2015) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Change in Taxes for 2 consecutive years, with $12474.0 the latest figure, recorded in Q3 2015.
- In Q3 2015, Change in Taxes fell 74.58% year-over-year to $12474.0; the TTM figure through Sep 2015 stood at $59173.0 (changed N/A YoY), while the FY2014 annual figure was $47940.0, up 423.44% from the prior year.
- Change in Taxes climbed to $12474.0 in Q3 2015 per PVLA's latest filing, from -$181.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $50564.0 in Q1 2014 and bottomed at -$2184.0 in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.93 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 12,474.00 |
| Jun 30, 2015 | -181.00 |
| Mar 31, 2015 | -2,184.00 |
| Sep 30, 2014 | 49,064.00 |
| Jun 30, 2014 | 49,668.00 |
| Mar 31, 2014 | 50,564.00 |